A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX.

The vLAMPS is a human, biomimetic liver MPS, in which the ECM and cell seeding of the intermediate layer prior to assembly, simplifies construction of the model and makes the platform user-friendly. This primarily glass microfluidic device is optimal for real-time imaging, while minimizing the binding of hydrophobic drugs/biologics to the materials that constitute the device. The assembly of the three layered device with primary human hepatocytes and liver sinusoidal endothelial cells (LSECs), and human cell lines for stellate and Kupffer cells, creates a vascular channel separated from the hepatic channel (chamber) by a porous membrane that allows communication between channels, recapitulating the 3D structure of the liver acinus. The vascular channel can be used to deliver drugs, immune cells, as well as various circulating cells and other factors to a stand-alone liver MPS and/or to couple the liver MPS to other organ MPS. We have successfully created continuous oxygen zonation by controlling the flow rates of media in the distinct vascular and hepatic channels and validated the computational modeling of zonation with oxygen sensitive and insensitive beads. This allows the direct investigation of the role of zonation in physiology, toxicology and disease progression. The vascular channel is lined with human LSECs, recapitulating partial immunologic functions within the liver sinusoid, including the activation of LSECs, promoting the binding of polymorphonuclear leukocytes (PMNs) followed by transmigration into the hepatic chamber. The vLAMPS is a valuable platform to investigate the functions of the healthy and diseased human liver using all primary human cell types and/or iPSC-derived cells.

[1]  Lucie A. Low,et al.  ‘You-on-a-chip’ for precision medicine , 2018 .

[2]  Younan Xia,et al.  Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications. , 2017, Chemical Society reviews.

[3]  Alan Wells,et al.  Liver ‘organ on a chip’ , 2017, Experimental cell research.

[4]  M. McConnell,et al.  Biology of portal hypertension , 2017, Hepatology International.

[5]  J. Wikswo,et al.  Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology , 2017, Experimental biology and medicine.

[6]  Chih-Huang Lai,et al.  Scaffold‐Free Liver‐On‐A‐Chip with Multiscale Organotypic Cultures , 2017, Advanced materials.

[7]  M. Shuler Organ-, body- and disease-on-a-chip systems. , 2017, Lab on a chip.

[8]  M. Radisic,et al.  Organ-on-a-chip devices advance to market. , 2017, Lab on a chip.

[9]  M. Watt,et al.  Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance , 2017, Nature Reviews Endocrinology.

[10]  Donald E. Ingber,et al.  SEBS elastomers for fabrication of microfluidic devices with reduced drug absorption by injection molding and extrusion , 2017 .

[11]  Albert Gough,et al.  Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems , 2017, Experimental biology and medicine.

[12]  Anup D. Sharma,et al.  Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems , 2017, Experimental biology and medicine.

[13]  A. Phillips,et al.  Immunofluorescence identifies distinct subsets of endothelial cells in the human liver , 2017, Scientific Reports.

[14]  Albert Gough,et al.  Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle , 2017, Scientific Reports.

[15]  D. L. Taylor,et al.  Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy. , 2017, Clinics in liver disease.

[16]  G. Groothuis,et al.  Judging the value of ‘liver-on-a-chip’ devices for prediction of toxicity , 2017, Expert opinion on drug metabolism & toxicology.

[17]  C. Denning,et al.  Small molecule absorption by PDMS in the context of drug response bioassays , 2017, Biochemical and biophysical research communications.

[18]  M. Bouchard,et al.  Human Liver Sinusoid on a Chip for Hepatitis B Virus Replication Study , 2017, Micromachines.

[19]  I. Amit,et al.  Single-cell spatial reconstruction reveals global division of labor in the mammalian liver , 2016, Nature.

[20]  S. Giannitelli,et al.  Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device , 2016, PloS one.

[21]  Alan Wells,et al.  Liver metastases: Microenvironments and ex-vivo models , 2016, Experimental biology and medicine.

[22]  Mandy B. Esch,et al.  Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue. , 2016, Lab on a chip.

[23]  Dong-Woo Cho,et al.  One-step fabrication of an organ-on-a-chip with spatial heterogeneity using a 3D bioprinting technology. , 2016, Lab on a chip.

[24]  Eric Leclerc,et al.  Long‐term human primary hepatocyte cultures in a microfluidic liver biochip show maintenance of mRNA levels and higher drug metabolism compared with Petri cultures , 2016, Biopharmaceutics & drug disposition.

[25]  GoughAlbert,et al.  The Microphysiology Systems Database for Analyzing and Modeling Compound Interactions with Human and Animal Organ Models. , 2016 .

[26]  Terry K Koo,et al.  A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. , 2016, Journal Chiropractic Medicine.

[27]  P. Knolle,et al.  Immunological functions of liver sinusoidal endothelial cells , 2016, Cellular & Molecular Immunology.

[28]  Jan Vanfleteren,et al.  Real-time monitoring of metabolic function in liver-on-chip microdevices tracks the dynamics of mitochondrial dysfunction , 2016, Proceedings of the National Academy of Sciences.

[29]  P. Cagle,et al.  Archives of pathology & laboratory medicine , 2016 .

[30]  Albert Gough,et al.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models , 2016, Experimental biology and medicine.

[31]  F. Jornayvaz,et al.  Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? , 2015, Molecular and Cellular Endocrinology.

[32]  Michael Bauer,et al.  A microfluidically perfused three dimensional human liver model. , 2015, Biomaterials.

[33]  Stefan Wölfl,et al.  In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells , 2015, PloS one.

[34]  Sang-Hoon Lee,et al.  3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip. , 2015, Lab on a chip.

[35]  A. Sanyal,et al.  Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease , 2015, Seminars in Liver Disease.

[36]  L. Griffith,et al.  Metabolite Profiling and Pharmacokinetic Evaluation of Hydrocortisone in a Perfused Three-Dimensional Human Liver Bioreactor , 2015, Drug Metabolism and Disposition.

[37]  K. Fisher,et al.  Drug-Induced Liver Injury. , 2015, Archives of pathology & laboratory medicine.

[38]  D. L. Taylor,et al.  Fluorescent protein biosensors applied to microphysiological systems , 2015, Experimental biology and medicine.

[39]  Michael L Shuler,et al.  Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow. , 2015, Lab on a chip.

[40]  Ronan M. T. Fleming,et al.  Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. , 2015, Biosensors & bioelectronics.

[41]  Martin D. Brennan,et al.  Oxygen control with microfluidics. , 2014, Lab on a chip.

[42]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[43]  R. Gebhardt,et al.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis. , 2014, World journal of gastroenterology.

[44]  L. Valerio Tenth anniversary of Expert Opinion on Drug Metabolism & Toxicology , 2014, Expert opinion on drug metabolism & toxicology.

[45]  Alan Wells,et al.  A microphysiological system model of therapy for liver micrometastases , 2014, Experimental biology and medicine.

[46]  Luke P. Lee,et al.  Physiologically relevant organs on chips , 2014, Biotechnology journal.

[47]  Manjunath Hegde,et al.  Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans , 2013, Stem Cell Research & Therapy.

[48]  R. Kamm,et al.  Oxygen levels in thermoplastic microfluidic devices during cell culture. , 2013, Lab on a chip.

[49]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[50]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[51]  Uwe Marx,et al.  Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput. , 2013, Lab on a chip.

[52]  Lucas H. Hofmeister,et al.  Scaling and systems biology for integrating multiple organs-on-a-chip. , 2013, Lab on a chip.

[53]  Jonathan D Posner,et al.  Simple replica micromolding of biocompatible styrenic elastomers. , 2013, Lab on a chip.

[54]  Thomas Singer,et al.  A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. , 2013, Toxicology and applied pharmacology.

[55]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[56]  S. Takayama,et al.  Quantitative Analysis of Molecular Absorption into PDMS Microfluidic Channels , 2012, Annals of Biomedical Engineering.

[57]  Hartmut Jaeschke,et al.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. , 2012, The Journal of clinical investigation.

[58]  S. Raghavan,et al.  Regulating oxygen levels in a microfluidic device. , 2011, Analytical chemistry.

[59]  Jan Böttger,et al.  “Artificial micro organs”—a microfluidic device for dielectrophoretic assembly of liver sinusoids , 2011, Biomedical microdevices.

[60]  Po Ki Yuen,et al.  Perfusion-based microfluidic device for three-dimensional dynamic primary human hepatocyte cell culture in the absence of biological or synthetic matrices or coagulants. , 2010, Lab on a chip.

[61]  N. LaRusso,et al.  Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis , 2010, Laboratory Investigation.

[62]  Matthew H. M. Lim,et al.  Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.

[63]  A. Sartorelli,et al.  Generation of Oxygen Deficiency in Cell Culture Using a Two-Enzyme System to Evaluate Agents Targeting Hypoxic Tumor Cells , 2008, Radiation research.

[64]  R. McCuskey The Hepatic Microvascular System in Health and Its Response to Toxicants , 2008, Anatomical record.

[65]  D. L. Le Couteur,et al.  The influence of oxygen tension on the structure and function of isolated liver sinusoidal endothelial cells , 2008, Comparative hepatology.

[66]  Luke P. Lee,et al.  Microfluidic environment for high density hepatocyte culture , 2008, Biomedical microdevices.

[67]  L. Hue,et al.  Cryopreservation of Human Hepatocytes Alters the Mitochondrial Respiratory Chain Complex 1 , 2007, Cell transplantation.

[68]  M. Yarmush,et al.  Integration of technologies for hepatic tissue engineering. , 2006, Advances in biochemical engineering/biotechnology.

[69]  S. Curbishley,et al.  Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. , 2006, World journal of gastroenterology.

[70]  Cheng-Hsien Liu,et al.  Rapid heterogeneous liver-cell on-chip patterning via the enhanced field-induced dielectrophoresis trap. , 2006, Lab on a chip.

[71]  S. Bhatia,et al.  In vitro zonation and toxicity in a hepatocyte bioreactor. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  Kjetil H Elvevold,et al.  Scavenger properties of cultivated pig liver endothelial cells , 2004, Comparative hepatology.

[73]  Bernhard Kadenbach,et al.  Intrinsic and extrinsic uncoupling of oxidative phosphorylation. , 2003, Biochimica et biophysica acta.

[74]  S. Bhatia,et al.  Formation of steady-state oxygen gradients in vitro: application to liver zonation. , 2003, Biotechnology and bioengineering.

[75]  Filip Braet,et al.  Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.

[76]  S. Dooley,et al.  Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts , 2001 .

[77]  S. I. Lee,et al.  Oxidative stress effect on the activation of hepatic stellate cells. , 2001, Yonsei medical journal.

[78]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[79]  K. Washington,et al.  Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver. , 2000, Human pathology.

[80]  Guido Gerken,et al.  Local control of the immune response in the liver , 2000, Immunological reviews.

[81]  K. Jungermann,et al.  Oxygen: Modulator of metabolic zonation and disease of the liver , 2000, Hepatology.

[82]  S. Yuan,et al.  Activated Neutrophils Induce Hyperpermeability and Phosphorylation of Adherens Junction Proteins in Coronary Venular Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[83]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[84]  E. Roberts,et al.  Extended primary culture of human hepatocytes in a collagen gel sandwich system , 1997, In Vitro Cellular & Developmental Biology - Animal.

[85]  Filip Braet,et al.  Structure and Function of Sinusoidal Lining Cells in the Liver , 1996, Toxicologic pathology.

[86]  R. Tompkins,et al.  Hepatocyte function and extracellular matrix geometry: long‐term culture in a sandwich configuration , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[87]  J. Smit,et al.  Paraformaldehyde fixation in immunofluorescence and immunoelectron microscopy. Preservation of tissue and cell surface membrane antigens. , 1974, Journal of immunological methods.

[88]  W. J. Meek,et al.  THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1938, Science.

[89]  Sung-Chul Lim World Journal of Gastroenterology , 2019 .

[90]  Manjunath Hegde,et al.  Long-term maintenance of a microfluidic 3D human liver sinusoid. , 2016, Biotechnology and bioengineering.

[91]  M. Martins-Green,et al.  An assay system for in vitro detection of permeability in human "endothelium". , 2008, Methods in enzymology.

[92]  H. Ito,et al.  Expression of epidermal growth factor in human tissues , 2005, Virchows Archiv A.

[93]  Bruno Stieger,et al.  Enterohepatic bile salt transporters in normal physiology and liver disease. , 2004, Gastroenterology.

[94]  M L Yarmush,et al.  Oxygen consumption characteristics of porcine hepatocytes. , 1999, Metabolic engineering.

[95]  R. Gebhardt Metabolic zonation of the liver: regulation and implications for liver function. , 1992, Pharmacology & therapeutics.

[96]  R P Mason,et al.  Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. , 1988, Chemico-biological interactions.

[97]  M. Black,et al.  Drug induced liver disease. , 1983, Postgraduate medical journal.

[98]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .

[99]  Rene,et al.  THE AMERICAN JOURNAL OF PHYSIOLOGY. , 1897, Science.